Singapore-based telehealth platform ORA raises US$10 mil Series A
With the new round of funding, ORA will seek to expand its presence into new territories.
Singapore-based telehealth platform ORA has raised US$10 million ($13.4 million) in its Series A, co-led by venture capital firms TNB Aura and Antler with participation from Gobi Partners, Kairous Capital and GMA Ventures.
This is the largest telehealth Series A raised in Southeast Asia, the company claims. The round brings the total funding to date to above US$17 million. TNB Aura is an approved co-investment partner of Enterprise Singapore.
ORA is a vertically integrated telehealth platform, delivering over 250,000 consultations and uninterrupted monthly growth since its launch in 2021.
ORA has launched three brands serving patients living with chronic conditions, aiming to make treatment more accessible, convenient and personal. “Modules” is a first-to-market personalised online dermatology service; “andSons” offers male health solutions; while “OVA” delivers female reproductive healthcare.
With the new round of funding, ORA will seek to expand its presence into new territories, both geography and new offerings-wise. ORA plans to bring its brands across 1300 tier one retail stores later this year, aside from looking at expansion opportunities into regions like the Gulf.
Click here to stay updated with the Latest Business & Investment News in Singapore
M1 and Fullerton Health to offer 5G-powered maritime telemedicine later this year
CDG invests $5.4 mil into teleoperation software company to boost autonomous vehicle capabilities
Read more stories about where the money flows, and analysis of the biggest market stories from Singapore and around the World
Get in-depth insights from our expert contributors, and dive into financial and economic trends